TrialHealth technology assessment (Winchester, England)2024

Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.

Nicola Curry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.